Oneblood Inc.

“The chief financial officer reviews the form 990. The form 990 is then presented to the enterprise risk and audit committee of the board for its review. The return is then presented to the board of directors for review and recommendation for approval before filing with the internal revenue service.”

“Every person who is an officer, director, member of a committee with board-delegated powers, or management-level employee (above department-head level) of oneblood, inc. Shall annually submit in writing to the board a statement which discloses all business transactions with related parties. Each such person shall have the continuing duty to update such disclosures in the event of a change of facts or knowledge. No party covered by the policy shall knowingly permit a business transaction to be entered into with a related party that is in violation of this policy, and parties covered by this policy shall take affirmative steps to report in writing to the chairperson of the board ("board chair") the relevant facts of a proposed transaction under consideration if such person believes that the proposed transaction may violate this policy. In the event that any person covered by the policy is unsure as to whether an existing or proposed arrangement constitutes or would constitute a business transaction with a related party, such person may request the board chair to have the governance and regulatory committee make a recommendation on the matter. If the matter is referred by the board chair to the governance committee, the governance committee shall issue a recommendation on the matter which shall be decided by the full board, whose decision shall be final. In considering the matter, any member of the governance committee with an interest in the outcome of the matter shall be recused from the discussion and voting on the matter in his or her capacity as a member of the governance committee. However, the governance committee may afford any party covered by the policy an opportunity to present arguments as part of its process in making a determination. Upon determination by the board that a party covered by the policy has violated it, the board shall take appropriate disciplinary and corrective action.”

“Oneblood, inc. Utilizes a third-party consultant to prepare a market data analysis, which is then summarized by the compensation department. The svp human resources and evp chief financial and administrative officer develops compensation recommendations for oneblood, inc.'s chief executive officer (ceo) and presents them to the compensation committee. The compensation committee may adjust the recommendations. The board of directors then reviews the recommendations and approves the ceo's compensation arrangement. Contemporaneous substantiation of the deliberations and approval is documented in oneblood's human resource files. This process last occurred in march 2025. Oneblood, inc. Participates in a number of annual surveys for all positions including senior management and executive team members. Surveys include industry specific, non-profit and general business surveys. Please see below for a partial listing of surveys participated in and resources used: - abc (america's blood centers) - florida hospital association - willis towers watson - companalyst - culpepper”

“The governance documents, conflict of interest policy, and audited financial statements are available on the organization's website for the same period of disclosure as set forth in irc section 6104(d). The organization's articles are available on sunbiz.org.”

“Change in investment in cts 11,525,763. Change in investment in oneblood foundation 2,452,527. Change in investment in proesis biologics -14,283,904.”

“Oneblood, inc. Has an enterprise risk and audit committee responsible for the oversight of the audit. This process did not change from the prior year.”